Acute lymphoblastic leukaemia: open trials in Russia

9 open trials have a site in Russia. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Moscow · Saint Petersburg
Registry updated 2026-07-06
NCT07366801
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Trial Treatment · Phase 2/3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow
Registry updated 2026-01-26
NCT07256210
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
Trial Treatment · Phase 2 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology, Moscow
Registry updated 2025-12-01
NCT06756152
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Trial Treatment · Phase 2/3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow
Registry updated 2025-01-01
NCT06721598
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
Research · National Research Center for Hematology, Russia
National Medical Research Center for Hematology, Moscow
Registry updated 2024-12-06
NCT06508099
Vitamin A and D Supplementation in Allogeneic HCT
Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University
RM Gorbacheva Research Institute, Saint Petersburg
Registry updated 2024-07-31
NCT05029531
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
Trial Treatment · Phase 3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow
Registry updated 2024-06-28
NCT06477549
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University
RM Gorbacheva Research Institute, Saint Petersburg
Registry updated 2024-06-27
NCT06237192
MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients
Trial Treatment · National Research Center for Hematology, Russia
Olga Aleshina, Moscow
Registry updated 2024-02-01

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error